# FDA 483 - David Young, D.O. - December 19, 2017

Source: https://www.globalkeysolutions.net/records/483/david-young-do/72d8f61c-852d-442d-ac60-3ce50b825659

> FDA 483 for David Young, D.O. on December 19, 2017. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: David Young, D.O.
- Inspection Date: 2017-12-19
- Product Type: drugs
- Office Name: Denver District Office
- Summary: An FDA inspection of Dr. David B. Young, D.O., a clinical investigator in Pleasant Grove, UT, revealed significant deficiencies in the conduct of clinical investigations. Observations included failures to adhere to the signed statement of investigator, maintain adequate and accurate case histories, and obtain legally effective informed consent from subjects. These issues indicate a lack of control over critical aspects of clinical trial management and subject protection.

## Related Officers

- [Theressa B. Smith](https://www.globalkeysolutions.net/people/theressa-b-smith/80f0c339-7eac-4c73-b9f6-ecb368738fe6)

Company: https://www.globalkeysolutions.net/companies/david-young-do/500de342-4fcd-445f-91d3-61056100ef11

Office: https://www.globalkeysolutions.net/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face